Breaking News
Get 45% Off 0
🤯 +96%, +62%, +40%: These AI-picked stocks are soaring!
See the list

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
Regeneron's Stock Falls As Mid-Stage Eye Disease Studies Fail By Zacks Investment Research - Nov 27, 2017

Regeneron Pharmaceuticals, Inc.’s (NASDAQ:REGN) shares were down 2.7% on Monday following the announcement of its plan of not advancing the nesvacumab and Eylea combination study to phase III...

Zacks Investment Research
Should Value Investors Consider Gulfport Energy (GPOR)? By Zacks Investment Research - Nov 27, 2017

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are...

Zacks Investment Research
Edwards Lifesciences' Pipeline Strong Amid Rising Expenses By Zacks Investment Research - Nov 27, 2017

On Nov 27, we issued an updated research report on Edwards Lifesciences Corporation (NYSE:EW) . The stock carries a Zacks Rank #3 (Hold).Edwards Lifesciences’ third-quarter 2017 performance was...

Zacks Investment Research
Stock Market News For Nov 28, 2017 By Zacks Investment Research - Nov 27, 2017

Benchmarks turned in mixed performances on Monday as the rally in retail stocks earlier in the session petered out. Moreover, energy shares declined after oil prices fell as investors speculated that...

Zacks Investment Research
2 Large-Cap Drug Stocks Missing Out On Industry Rally In '17 By Zacks Investment Research - Nov 27, 2017

After the drug pricing issue crippled its performance last year, the drug/biotech industry, except for a small correction recently, has witnessed a turnaround this year. Stocks with large market cap...

Zacks Investment Research
2600 Holds In Flat Session By Zacks Investment Research - Nov 27, 2017

With the Thanksgiving holiday and Black Friday now behind us, the market was kind of groggy as it got back to work on Cyber Monday. The major indices each hit new records intraday, but weren’t...

Zacks Investment Research
Why Is GOL Linhas (GOL) Stock Up More Than 200% This Year? By Zacks Investment Research - Nov 27, 2017

Shares of GOL Linhas Aéreas Inteligentes S.A. (NYSE:GOL) have skyrocketed 239.2%, comfortably outperforming the Zacks Airline industry’s rally of 13.7% on a year-to-date basis.In fact,...

Zacks Investment Research
5 Reasons To Add Flagstar Bancorp (FBC) To Your Portfolio By Zacks Investment Research - Nov 27, 2017

A strong balance sheet position and improving credit quality make Flagstar Bancorp (NYSE:FBC) an attractive pick now. Further, the bank’s cost-control initiatives are impressive.Given the...

Zacks Investment Research
Philips Teams Up With 3D Systems, Stratasys For 3D Printing By Zacks Investment Research - Nov 27, 2017

After launching IntelliSpace Portal 10, Koninklijke Philips N.V. (NYSE:PHG) strengthened its advanced 3D modeling capabilities further by signing agreements with 3D Systems Corporation (NYSE:DDD) ...

Zacks Investment Research
Can Wireless Network Infrastructure Market Sustain Momentum? By Zacks Investment Research - Nov 27, 2017

As per reports from SNS Research, the wireless or mobile network infrastructure industry is expected to grow at a rate of 2% over the next three years.Per projections, the market will witness an...

Zacks Investment Research
Noble Energy Continues To Divest, Sells Assets For $340M By Zacks Investment Research - Nov 27, 2017

Per a media report, Noble Energy, Inc (NYSE:NBL) has entered into an agreement to divest minerals and royalty package to Houston-based Black Stone Minerals LP (NYSE:BSM) for $340 million.Per the...

Zacks Investment Research
Will Dillard's (DDS) Stock Rise Further Post Q3 Earnings? By Zacks Investment Research - Nov 27, 2017

Dillard's, Inc. (NYSE:DDS) is well positioned to benefit from its growth strategies. Also, the recent upward estimate revisions after the company reported better-than-expected third-quarter fiscal...

Continue with Apple
Continue with Google
or
Sign up with Email